Deal Announcements

MolecularMD Secures New Funding Of $3 Million

Monday, February 02, 2009 5:58:00 AM PDT | VentureDeal Staff

Portland, Oregon  --  Biotechnology company MolecularMD has garnered $3 million in investment venture capital.

MolecularMD specializes in the development and commercialization of genomic assays to measure patient response to targeted cancer therapies.

Ballast Point Venture Partners made the investment. The company said that the financing would be "used to build MolecularMD's corporate infrastructure and to expand the company's assay portfolio."

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1